Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 84.74M | 115.61M | 165.96M | 174.19M | 202.71M | 158.41M |
Gross Profit | 14.29M | 20.05M | 18.77M | 38.17M | 58.21M | 58.95M |
EBITDA | -31.87M | -46.49M | -22.02M | -64.65M | -17.04M | -29.62M |
Net Income | -79.37M | -99.67M | -62.38M | -107.46M | -45.12M | -52.11M |
Balance Sheet | ||||||
Total Assets | 138.29M | 151.32M | 231.19M | 293.98M | 415.18M | 429.60M |
Cash, Cash Equivalents and Short-Term Investments | 772.00K | 3.00M | 2.03M | 2.20M | 6.95M | 7.43M |
Total Debt | 96.22M | 129.63M | 109.99M | 105.91M | 98.47M | 85.01M |
Total Liabilities | 200.71M | 188.53M | 168.79M | 172.46M | 181.15M | 146.56M |
Stockholders Equity | -62.42M | -37.20M | 62.39M | 121.35M | 233.86M | 283.05M |
Cash Flow | ||||||
Free Cash Flow | 3.08M | -1.08M | 4.65M | -6.53M | -12.29M | 7.75M |
Operating Cash Flow | 5.61M | -189.00K | 5.37M | 8.61M | -8.82M | 9.65M |
Investing Cash Flow | -2.37M | -742.00K | 13.17M | -16.84M | 872.00K | -2.52M |
Financing Cash Flow | -3.02M | 1.91M | -18.69M | 4.78M | 6.02M | -2.91M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
61 Neutral | $17.78B | 13.97 | -5.40% | 3.03% | 1.50% | -15.71% | |
40 Underperform | C$213.77M | ― | -955.11% | ― | -40.23% | -5.31% | |
― | $390.21M | ― | -98.42% | ― | ― | ― | |
― | $221.50M | 117.61 | 1.86% | ― | ― | ― | |
― | $299.85M | 97.05 | -0.70% | ― | ― | ― | |
54 Neutral | C$584.17M | ― | -45.36% | ― | -12.25% | -47.36% | |
― | $165.29M | ― | -554.70% | ― | ― | ― |
TILT Holdings Inc. reported its second-quarter 2025 results, highlighting a strategic shift towards an asset-light business model focused on Jupiter, its vaporization hardware platform. The company achieved regulatory approval for a dispensary sale in Massachusetts and is pursuing strategic alternatives for its Ohio and Massachusetts assets, marking a planned exit from plant-touching operations. This transition aims to simplify operations and improve capital efficiency. Despite a decrease in revenue due to a shift to a commission-based model and macroeconomic pressures, the company remains confident in its strategy, focusing on innovation and global market expansion.
TILT Holdings reported its second quarter 2025 results, highlighting a strategic shift towards an asset-light business model centered on its Jupiter segment. The company achieved regulatory milestones and is exiting plant-touching operations in Massachusetts and Ohio, aiming to simplify operations and enhance capital efficiency. Despite a decrease in revenue due to a transition to a commission-based model and supply chain challenges, TILT remains focused on expanding its vaporization hardware offerings globally. The financial results showed a net loss improvement and positive cash flow from continuing operations, reflecting the company’s strategic realignment.
TILT Holdings Inc. reported its financial results for the first quarter of 2025, highlighting a strategic shift towards a more asset-light operating model by divesting plant-touching assets. This move is expected to enhance the company’s scalability and financial performance. The company achieved a significant milestone with the EU medical device certification for its Jupiter handheld liquid vaporizer, indicating a focus on innovation and improved patient care. Despite a decrease in revenue and a net loss, TILT is making progress in repositioning itself in a challenging market environment, with a focus on sustainable growth and margin improvement.
TILT Holdings Inc. reported its first quarter 2025 results, highlighting a strategic shift towards an asset-light, Jupiter-first business model by divesting plant-touching assets. This transition aims to expand market reach and improve financial performance, despite a decrease in revenue and an increased net loss compared to the previous year. The company achieved a significant milestone with the EU certification of its Jupiter QMID vaporizer, enhancing its innovation in medical cannabis delivery.